22
Participants
Start Date
February 28, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Lyral®
Alergen panel containing ascending doses of Lyral (0.10 mg/cm\^2, 0.20 mg/cm\^2 and 0.40 mg/cm\^2) and negative control
University of Southern Denmark Institute of Clinical Research, Odense
Lead Sponsor
Allerderm
INDUSTRY